Advanced Search

    Technical Analysis for ATRA - Atara Biotherapeutics, Inc.

    Grade Last Price % Change Price Change
    F 2.87 0.35% 0.01
    ATRA closed up 0.35 percent on Friday, March 24, 2023, on 1.46 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical ATRA trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Down Weakness 0.00%
    Wide Bands Range Expansion 0.35%
    Wide Bands Range Expansion 0.00%
    Shooting Star Candlestick Bearish -4.97%
    180 Bearish Setup Bearish Swing Setup -4.97%
    Doji - Bearish? Reversal -4.97%
    Wide Bands Range Expansion -4.97%
    Older End-of-Day Signals for ATRA ...

       Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

    Alert Time
    Possible NR7 about 11 hours ago
    Up 1% about 13 hours ago
    Gap Down Closed about 13 hours ago
    1.5x Volume Pace about 13 hours ago
    Reversed from Down about 13 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators Basic chart:

    Profile

    Atara Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of muscle wasting conditions and oncology. Its lead product candidate is PINTA 745, which is in a Phase II clinical trial for the treatment of protein-energy wasting in end-stage renal disease patients. The company is also developing STM 434, a targeted therapy for ovarian cancer and other solid tumors; and a pipeline of product candidates that are in preclinical development. Atara Biotherapeutics, Inc. was founded in 2012 and is headquartered in Brisbane, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Clinical Medicine Solid Tumors Drugs Clinical Development Ovarian Cancer Targeted Therapy End Stage Renal Disease Renal Disease Stage Renal Disease

    Is ATRA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Mar 24 Atara Biotherapeutics (ATRA) Loses -33.02% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
    Mar 12 Atara Biotherapeutics (ATRA) Investor Presentation - Slideshow
    Mar 11 Sangamo, Protagonist, and Eiger among biotechs with exposure to Silicon Valley Bank
    Mar 3 Atara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Mar 3 Are Medical Stocks Lagging Apexigen, Inc. (APGN) This Year?
    Mar 1 Atara Biotherapeutics to Participate in Cell Therapy Panel Discussion at the Cowen 43rd Annual Health Care Conference
    Feb 21 Atara Biotherapeutics to Participate in the H.C. Wainwright Cell Therapy Virtual Conference
    Feb 17 Atara Biotherapeutics, Inc. 2023 Q4 - Results - Earnings Call Presentation
    Feb 15 The past five years for Atara Biotherapeutics (NASDAQ:ATRA) investors has not been profitable
    Feb 9 Atara Biotherapeutics: A Speculative Buy After A Difficult Year
    See more ATRA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 10.01
    52 Week Low 2.66
    Average Volume 1,156,281
    200-Day Moving Average 4.38
    50-Day Moving Average 4.03
    20-Day Moving Average 3.26
    10-Day Moving Average 3.01
    Average True Range 0.25
    RSI 31.97
    ADX 38.93
    +DI 11.43
    -DI 32.19
    Chandelier Exit (Long, 3 ATRs) 3.55
    Chandelier Exit (Short, 3 ATRs) 3.41
    Upper Bollinger Bands 4.03
    Lower Bollinger Band 2.50
    Percent B (%b) 0.24
    BandWidth 46.87
    MACD Line -0.34
    MACD Signal Line -0.34
    MACD Histogram -0.0029
    Fundamentals Value
    Market Cap 223.04 Million
    Num Shares 77.7 Million
    EPS -6.07
    Price-to-Earnings (P/E) Ratio -0.47
    Price-to-Sales 0.00
    Price-to-Book 5.14
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.06
    Resistance 3 (R3) 3.05 2.97 3.03
    Resistance 2 (R2) 2.97 2.92 2.98 3.02
    Resistance 1 (R1) 2.92 2.89 2.95 2.93 3.01
    Pivot Point 2.85 2.85 2.86 2.85 2.85
    Support 1 (S1) 2.80 2.80 2.82 2.81 2.73
    Support 2 (S2) 2.72 2.77 2.73 2.72
    Support 3 (S3) 2.67 2.72 2.71
    Support 4 (S4) 2.68